The US healthcare environment is poised for fundamental shifts as manufacturers, payers, and other stakeholders navigate a confluence of regulatory reforms, evolving market pressures, and changing patient expectations. ​

Our live webinar offers actionable insights into how your team can maximize opportunity amid shifts in drug pricing, commercialization, and regulatory oversight.

Tune in January 27 at 11 AM ET / 4 PM GMT, to hear Avalere Health Advisory and Marketing experts delve into the key trends shaping 2026 and how you can power what’s possible for your team in three areas: ​

• Navigating a new era of drug pricing and market access: Pharmaceutical pricing, marketing, and commercialization will face sweeping changes in 2026—from Most-Favored Nation pricing pressures and ACNU-driven over-the-counter expansion to the rise of direct-to-consumer drug platforms.​
• Redefining health coverage for evolving market demands: Health plans must adapt to increasing pressure as Medicare Advantage Star Ratings evolve, OBBBA Medicaid provisions reshape coverage across markets, and employer-sponsored costs continue to climb.​
• Shaping the future of vaccines and GLP-1s: Rapidly shifting federal vaccine policy and the emergence of GLP-1 therapies require new strategies for access, affordability, and evidence generation.